Valproic acid adjunctive therapy for HIV-associated cognitive impairment: A first report

被引:67
|
作者
Schifitto, G
Peterson, DR
Zhong, J
Ni, H
Cruttenden, K
Gaugh, M
Gendelman, HE
Boska, M
Gelbard, H
机构
[1] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biostat, Rochester, NY 14642 USA
[3] Univ Rochester, Med Ctr, Dept Radiol, Rochester, NY 14642 USA
[4] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA
[5] Univ Nebraska, Med Ctr, Dept Radiol, Omaha, NE 68105 USA
关键词
D O I
10.1212/01.wnl.0000204294.28189.03
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In vitro and animal model data demonstrate that valproic acid (VPA) can ameliorate HIV-associated neurotoxicity. The authors conducted a pilot 10-week placebo-controlled study of VPA 250 mg twice daily in 22 HIV-infected individuals with (n = 16) and without (n = 6) cognitive impairment. VPA was safe and well tolerated, with trends toward improved neuropsychological performance and brain metabolism in the impaired subjects.
引用
收藏
页码:919 / 921
页数:3
相关论文
共 50 条
  • [31] Has HIV-associated neurocognitive disorders now transformed into vascular cognitive impairment?
    Brew, Bruce J.
    AIDS, 2016, 30 (15) : 2379 - 2380
  • [32] Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment
    Cantres-Rosario, Yisel M.
    Acevedo-Mariani, Frances M.
    Perez-Laspiur, Juliana
    Haskins, William E.
    Plaud, Marines
    Cantres-Rosario, Yadira M.
    Skolasky, Richard
    Mendez-Bermudez, Israel
    Wojna, Valerie
    Melendez, Loyda M.
    PLOS ONE, 2017, 12 (07):
  • [33] Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
    Ronald J. Ellis
    María J. Marquine
    Marcus Kaul
    Jerel Adam Fields
    Johannes C. M. Schlachetzki
    Nature Reviews Neurology, 2023, 19 : 668 - 687
  • [34] Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment
    Marder, K
    Albert, SM
    McDermott, MP
    McArthur, JC
    Schifitto, G
    Selnes, OA
    Sacktor, N
    Stern, Y
    Palumbo, D
    Kieburtz, K
    Cohen, B
    Orme, C
    Epstein, LG
    NEUROLOGY, 2003, 60 (09) : 1467 - 1473
  • [35] Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
    Ellis, Ronald J.
    Marquine, Maria J.
    Kaul, Marcus
    Fields, Jerel Adam
    Schlachetzki, Johannes C. M.
    NATURE REVIEWS NEUROLOGY, 2023, 19 (11) : 668 - 687
  • [36] Distinguishing Amnestic Mild Cognitive Impairment From HIV-Associated Neurocognitive Disorders
    Sundermann, Erin E.
    Bondi, Mark W.
    Campbell, Laura M.
    Gouaux, Ben
    Moore, Raeanne C.
    Soontornniyomkij, Virawudh
    Moore, David J.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (03): : 435 - 442
  • [37] Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment
    Kieburtz, K
    Schifitto, G
    McDermott, M
    Heo, M
    Irvine, C
    Palumbo, D
    Orme, C
    Zimmerman, C
    Gelbard, H
    Hickey, C
    Casaceli, C
    Guthrie, B
    Rumfola, L
    Epstein, L
    Marder, K
    Ramachandran, G
    Albert, S
    Dooneief, G
    Stern, Y
    Todak, G
    FriedmanClouse, R
    Polanco, C
    Winston, T
    Mayeux, R
    DalPan, G
    Selnes, O
    Sacktor, N
    Hasenauer, D
    Esposito, D
    NanceSproson, L
    McArthur, JC
    Shoulson, I
    Oakes, D
    Reichman, R
    OSullivan, J
    NEUROLOGY, 1997, 49 (01) : 142 - 146
  • [38] HIV-Associated Cognitive Impairment in Perinatally Infected Children: A Meta-analysis
    Phillips, Nicole
    Amos, Taryn
    Kuo, Caroline
    Hoare, Jacqueline
    Ipser, Jonathan
    Thomas, Kevin G. F.
    Stein, Dan J.
    PEDIATRICS, 2016, 138 (05)
  • [39] Selegiline transdermal system (STS) for HIV-associated cognitive impairment: Open-label report of ACTG 5090
    Evans, Scott R.
    Yeh, Tzu-min
    Sacktor, Ned
    Clifford, David B.
    Simpson, David
    Miller, Eric N.
    Ellis, Ronald J.
    Valcour, Victor
    Marra, Christina M.
    Millar, Linda
    Schifitto, Giovanni
    HIV CLINICAL TRIALS, 2007, 8 (06): : 437 - 446
  • [40] Minocycline treatment for HIV-associated cognitive impairment Results from a randomized trial
    Sacktor, N.
    Miyahara, S.
    Deng, L.
    Evans, S.
    Schifitto, G.
    Cohen, B. A.
    Paul, R.
    Robertson, K.
    Jarocki, B.
    Scarsi, K.
    Coombs, R. W.
    Zink, M. C.
    Nath, A.
    Smith, E.
    Ellis, R. J.
    Singer, E.
    Weihe, J.
    McCarthy, S.
    Hosey, L.
    Clifford, D. B.
    NEUROLOGY, 2011, 77 (12) : 1135 - 1142